KWALITY PHARMACEUTICALS L (KPL)

NSE: ₹2,375.20
BSE: ₹2,382.85
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 67.45 69.65 78.10 91.98 80.08 90.03 84.41 115.68 111.48 111.31 123.44 156.82
YOY Revenue Growth % -3.94% 24.46% 39.43% 33.68% 18.72% 29.27% 8.08% 25.77% 39.21% 23.63% 46.25% 35.57%
Other Income 0.40 0.23 0.62 0.58 0.28 0.22 0.65 0.77 0.38 0.90 0.53 1.06
Total Income 67.85 69.88 78.71 92.56 80.36 90.26 85.06 116.44 111.85 112.21 123.97 157.88
Total Expenses + 60.61 61.67 68.94 79.22 69.22 77.67 73.65 97.35 94.81 93.76 100.79 126.23
Cost of Materials Consumed 33.48 33.06 39.54 47.73 37.43 38.91 36.79 52.29 49.98 54.05 57.11 79.68
Employee Benefit Expense 7.62 7.92 8.00 8.98 9.72 10.30 11.07 12.68 12.15 13.31 14.36 14.22
Other Expenses 12.97 12.32 13.44 16.10 13.99 16.10 17.11 16.31 17.11 17.76 20.03 17.46
Operating Profit 6.84 7.98 9.16 12.76 10.86 12.36 10.76 18.33 16.66 17.55 22.65 30.59
OPM % 10.1% 11.5% 11.7% 13.9% 13.6% 13.7% 12.7% 15.8% 14.9% 15.8% 18.4% 19.5%
Profit Before Tax + 7.24 8.21 9.78 6.24 11.14 12.58 11.41 19.09 17.04 18.45 22.35 31.65
Tax Expense 1.79 1.95 2.07 1.75 2.77 4.10 2.87 4.59 5.11 4.33 6.35 6.36
Tax % 24.8% 23.8% 21.2% 28% 24.9% 32.6% 25.2% 24.1% 30% 23.5% 28.4% 20.1%
Profit After Tax 5.45 6.26 7.70 4.50 8.37 8.49 8.54 14.50 11.93 14.12 16.01 25.29
EPS (Basic) 5.17 6.03 7.42 4.33 8.06 8.18 8.23 13.97 11.50 13.60 15.43 24.37

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 503.06 370.20 307.17 250.99 456.13 261.50 138.68
YOY Revenue Growth % 35.89% 20.52% 22.38% -44.97% 74.43% 88.56% -
Other Income 2.86 1.92 1.83 2.94 3.51 1.59 3.92
Total Income 505.92 372.12 309.00 253.94 459.64 263.09 142.60
Total Expenses + 415.60 317.89 270.44 211.65 297.97 241.29 131.46
Cost of Materials Consumed 240.81 165.41 153.81 113.22 199.31 165.28 91.92
Employee Benefit Expense 54.04 43.76 32.53 29.90 20.09 15.68 11.69
Other Expenses 72.36 63.51 54.83 50.74 63.72 50.97 25.81
Operating Profit 87.46 52.31 36.74 39.35 158.16 20.21 7.22
OPM % 17.4% 14.1% 12% 15.7% 34.7% 7.7% 5.2%
Profit Before Exceptional 90.32 54.23 38.57 42.29 0.00 0.00 0.00
Exceptional Items -0.83 0.00 -7.10 -16.53 0.00 0.00 0.00
Profit Before Tax + 89.49 54.23 31.47 25.76 161.67 21.80 11.14
Tax Expense 22.15 14.34 7.48 6.29 161.67 21.80 11.14
Tax % 24.7% 26.4% 23.8% 24.4% 100% 100% 100%
Profit After Tax 67.35 39.89 23.98 19.47 0.00 0.00 0.00
EPS (Basic) 64.90 38.44 23.11 18.45 115.70 14.86 8.13

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 188.87 165.82 154.19 149.06 115.36 62.90 46.15
Property, Plant & Equipment 148.52 142.76 138.18 119.57 0.00 0.00 0.00
Capital Work in Progress 17.01 0.00 0.00 14.29 0.00 0.00 0.00
Non-Current Investments 3.55 3.55 3.55 3.55 4.33 4.28 4.20
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 5.85 1.71 0.00 0.00 0.00 0.00 0.00
Current Assets + 406.79 284.90 243.38 207.52 227.32 105.88 88.53
Inventories 78.25 83.47 78.39 86.31 53.36 17.36 22.42
Trade Receivables 281.22 155.90 115.98 73.29 0.00 0.00 0.00
Cash and Cash Equivalents 0.68 11.55 1.35 1.80 10.87 5.13 1.15
Current Investments 0.00 0.00 0.00 0.00 0.00 4.44 3.34
LIABILITIES & EQUITY
Total Equity 333.37 265.84 225.95 202.03 0.00 0.00 0.00
Equity Share Capital 10.38 10.38 10.38 10.38 0.00 0.00 0.00
Other Equity 323.00 255.47 215.57 191.65 0.00 0.00 0.00
Non-Current Liabilities 36.77 15.37 19.78 28.62 30.50 28.12 19.98
Current Liabilities 225.52 169.51 151.85 125.94 129.62 78.15 67.61
Total Liabilities 262.29 184.88 171.63 154.56 0.00 0.00 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities 17.00 52.77 43.35 42.19 63.06 26.36 0.00
Cash from Investing Activities -34.91 -28.13 -26.40 -48.44 -62.98 -23.20 0.00
Cash from Financing Activities 7.04 -14.44 -17.40 0.99 5.66 0.83 0.00
Net Increase/Decrease in Cash -10.87 10.20 -0.45 -5.26 5.74 3.99 0.00